French cosmetics giant L’Oreal SA said on Thursday that the COVID-19 pandemic impacted sales last year, but that its e-commerce efforts helped it limit the drop to the single digits.
With restrictions closing beauty salons and many people working from home, sales in both the professional and consumer segments took a hit, but overall the drop was 6.3 percent to 28 billion euros (US$34 billion) for the year as a whole.
Meanwhile, net profits at the firm, which includes brands such as Maybelline and Redken, slid 5 percent to 3.6 billion euros.
“In 2020, the COVID-19 pandemic, which spread across the world, triggered a crisis of supply due to the widespread closure of points of sale which led to an unprecedented, if temporary, decline of the beauty market,” chief executive Jean-Paul Agon said in an earnings statement. “Thanks to its strength in digital and e-commerce, which has again increased considerably during the crisis, L’Oreal has been able to ... compensate to a large extent for the closure of points of sale.”
The company said its online sales shot 62 percent higher and accounted for a record 26.6 percent of total sales.
Asia-Pacific is now L’Oreal’s biggest region and was the only one to post growth for last year overall and during the fourth quarter.
If sales of professional products have largely recovered, dipping by 1.4 percent in the fourth quarter, consumer products were still down by 6.9 percent.
Luxury products, L’Oreal’s biggest segment, which includes brands such as Lancome and Kiehl’s, returned to growth in the final three months of last year, climbing by 3.3 percent to 3.2 billion euros.
Active cosmetics, a segment that includes La Roche-Posay and SkinCeuticals, saw the strongest growth in the fourth quarter, jumping by 20.4 percent.
Management proposed a dividend of 4 euros, an increase of 3.9 percent.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained